BioScrip (BIOS) Misses Q4 EPS by 11c
Tweet
Share
E-mailGet Alerts BIOS Hot Sheet
Price: $10.80 --0%
Financial Fact:
Cost of revenue: 161.96M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Cost of revenue: 161.96M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
BioScrip (NASDAQ: BIOS) reported Q4 EPS of ($0.14), $0.11 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $183.6 million versus the consensus estimate of $188.41 million.
For earnings history and earnings-related data on BioScrip (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- OceanaGold to acquire Ausgold in a deal valued at A$776M
- JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
